Browsing by Subject "astrocyte"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
Item Chemokine CXCL8 Mediated Intercellular Interactions in HIV-1 associated Dementia(2013-12-01) Mamik, Manmeet K.; Ghorpade, AnujaThis dissertation explores the role of chemokine CXCL8 during human immune deficiency virus (HIV)-1 infection in the brain. Chemokine CXCL8 is an important neutrophil chemoattractant implicated in various neurodegenerative disorders. It is upregulated in the brains and cerebrospinal fluid of HIV-1 infected individuals suggesting its potential role in HIV-1 associated neuroinflammation. Astrocytes are known to be the major contributors to the CXCL8 pool. Interleukin (IL)-1β activated astrocytes exhibit significant upregulation of CXCL8. In order to determine the signaling pathways involved in CXCL8 regulation in astrocytes, we employed pharmacological inhibitors for non-receptor Src homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and mitogen-activated protein kinases (MAPK) pathway and observed reduced expression of CXCL8 following IL-1β stimulation. Thus, our findings suggest an important role for SHP2 in CXCL8 expression in astrocytes during inflammation, as SHP2, directly or indirectly, modulates p38 and extracellular signal regulated kinase (ERK) MAPK in the signaling cascade leading to CXCL8 production. In the post-antiretroviral therapy (ART) era, low level of productive replication of HIV-1 in brain is a critical component of neuropathogenesis regulation. HIV-1 replication is a complex mechanism involving both host and viral factors. The majority of viral replication in brain occurs in perivascular macrophages and/or 2 microglia. In this study, we investigated the effect of CXCL8 on productive infection of HIV-1 in human monocytes-derived macrophages (MDM) and primary human microglia. The results show that CXCL8 mediates productive infection of HIV-1 in MDM and microglia via receptors CXCR1 and CXCR2 and induces HIV-1 long terminal repeat (LTR) promoter activity. Detailed understanding of astrocyte signaling and HIV-1 replication, as presented in the thesis, will be relevant to glial-neuronal interactions, which are central to neuroinflammation in HIV-1 and many other neurodegenerative conditions. Also, modulation of levels of CXCL8 can be a therapeutic strategy for control of productive HIV-1 replication in the brain.Item Connexin 43 Contributes to Estrogen Protection against Oxidative Stress in Cortical Astrocytes(2019-05) Kubelka, Nicholas K.; Singh, Meharvan; Uht, Rosalie M.; Schreihofer, Derek A.; Yang, Shaohua; Planz, John V.Age-related brain disorders are associated with the decline in the ability of brain cells to cope with homeostatic challenge. Although all major brain cell types have the capacity to respond to homeostatic challenges, astrocytes are particularly well-equipped to counteract these challenges. Here, we focused on Connexin 43 (Cx43) as a protein that is not only highly expressed in astrocytes, but whose expression is critical to inter-cellular communication that in turn, can influence cell viability. Most studies to date have focused on the expression (i.e., abundance) of Cx43. However, a critical limitation of these studies is that they did not thoroughly examine functionality of the Cx43 channels. In particular, there is a paucity of data describing the differential contributions of Cx43-containing hemichannels versus Cx43-containing gap junctions to cellular functions. We hypothesized the astrocyte Cx43 hemichannel as a yet unreported target of androgens and estrogens based on three notions. First, our laboratory has determined that astrocytes are a relevant and important target of such gonadal steroid hormones as estrogens (e.g., 17[beta]-estradiol (abbreviated herein as estradiol or E2)) and androgens (such as DHT), through which these hormones promote healthy brain cell function. Second, oxidative stress is associated with an increase in Cx43 opening. Finally, the Cx43 gene promoter contains functional estrogen response element (ERE) half sites, and estradiol, as well as other estrogenic compounds, decrease Cx43 channel opening in peripheral (non-CNS) tissue. Based on these notions, we hypothesized that gonadal androgens and estrogens will inhibit Cx43 hemichannel opening in cortical astrocytes as well. My data revealed that while E2, dihydrotestosterone (DHT), and the estrogenic metabolite of DHT (3[beta]diol) all protect primary cortical astrocytes from the mixed metabolic/oxidative insult, iodoacetic acid (IAA), only DHT decreased astrocyte Cx43 mRNA expression. Consistent with their cytoprotective effects, however, all three steroids decrease astrocyte Cx43 hemichannel opening, and antagonized the increased opening of Cx43 hemichannels induced by IAA. In an effort to pursue the mechanism by which these steroids reduced Cx43 hemichannel opening, we evaluated the phosphorylation of Cx43 at two key residues, Ser 368 and Tyr 265. Phosphorylation at these residues is associated with channel closing, and as such, we predicted that the three hormones would increase the phosphorylation of Cx43 at one or both of these residues. Whereas Tyr265 phosphorylation was unaffected any of the three hormones, DHT significantly reduced the phosphorylation of Cx43 at Ser368. These observations may indicate that while all three steroids contribute to astrocyte protection through a mechanism that involves blocking astrocyte Cx43 hemichannel opening, DHT may induce molecular changes in the astrocytes that are distinct from those induced by estradiol or 3[beta]diol. The knowledge gained through the experiments conducted not only enhance our understanding of how Cx43 hemichannels and Cx43 gap junctions influence astrocyte function and viability but also define Cx43 hemichannels as relevant targets of gonadal steroid hormone induced regulation of cell viability. Such knowledge may facilitate the development of more precise therapeutics (i.e., selectively targeting Cx43 hemichannels without activity at Cx43 gap junctions in the same cells or tissue), the benefit of which would be to better treat age-associated neurodegenerative disorders as well as disorders of peripheral tissueItem Crosstalk Between Dysfunctional Mitochondria and Inflammation in Glaucomatous Neurodegeneration(Frontiers Media S.A., 2021-07-21) Jassim, Assraa Hassan; Inman, Denise M.; Mitchell, Claire H.Mitochondrial dysfunction and excessive inflammatory responses are both sufficient to induce pathology in age-dependent neurodegenerations. However, emerging evidence indicates crosstalk between damaged mitochondrial and inflammatory signaling can exacerbate issues in chronic neurodegenerations. This review discusses evidence for the interaction between mitochondrial damage and inflammation, with a focus on glaucomatous neurodegeneration, and proposes that positive feedback resulting from this crosstalk drives pathology. Mitochondrial dysfunction exacerbates inflammatory signaling in multiple ways. Damaged mitochondrial DNA is a damage-associated molecular pattern, which activates the NLRP3 inflammasome; priming and activation of the NLRP3 inflammasome, and the resulting liberation of IL-1beta and IL-18 via the gasdermin D pore, is a major pathway to enhance inflammatory responses. The rise in reactive oxygen species induced by mitochondrial damage also activates inflammatory pathways, while blockage of Complex enzymes is sufficient to increase inflammatory signaling. Impaired mitophagy contributes to inflammation as the inability to turnover mitochondria in a timely manner increases levels of ROS and damaged mtDNA, with the latter likely to stimulate the cGAS-STING pathway to increase interferon signaling. Mitochondrial associated ER membrane contacts and the mitochondria-associated adaptor molecule MAVS can activate NLRP3 inflammasome signaling. In addition to dysfunctional mitochondria increasing inflammation, the corollary also occurs, with inflammation reducing mitochondrial function and ATP production; the resulting downward spiral accelerates degeneration. Evidence from several preclinical models including the DBA/2J mouse, microbead injection and transient elevation of IOP, in addition to patient data, implicates both mitochondrial damage and inflammation in glaucomatous neurodegeneration. The pressure-dependent hypoxia and the resulting metabolic vulnerability is associated with mitochondrial damage and IL-1beta release. Links between mitochondrial dysfunction and inflammation can occur in retinal ganglion cells, microglia cells and astrocytes. In summary, crosstalk between damaged mitochondria and increased inflammatory signaling enhances pathology in glaucomatous neurodegeneration, with implications for other complex age-dependent neurodegenerations like Alzheimer's and Parkinson's disease.Item Hyperglycemia Alters Astrocyte Metabolism and Inhibits Astrocyte Proliferation(JKL International, 2018-08-01) Li, Wenjun; Roy Choudhury, Gourav; Winters, Ali; Prah, Jude; Lin, Wenping; Liu, Ran; Yang, ShaohuaDiabetes milieu is a complex metabolic disease that has been known to associate with high risk of various neurological disorders. Hyperglycemia in diabetes could dramatically increase neuronal glucose levels which leads to neuronal damage, a phenomenon referred to as glucose neurotoxicity. On the other hand, the impact of hyperglycemia on astrocytes has been less explored. Astrocytes play important roles in brain energy metabolism through neuron-astrocyte coupling. As the component of blood brain barrier, glucose might be primarily transported into astrocytes, hence, impose direct impact on astrocyte metabolism and function. In the present study, we determined the effect of high glucose on the energy metabolism and function of primary astrocytes. Hyperglycemia level glucose (25 mM) induced cell cycle arrest and inhibited proliferation and migration of primary astrocytes. Consistently, high glucose decreased cyclin D1 and D3 expression. High glucose enhanced glycolytic metabolism, increased ATP and glycogen content in primary astrocytes. In addition, high glucose activated AMP-activated protein kinase (AMPK) signaling pathway in astrocytes. In summary, our in vitro study indicated that hyperglycemia might impact astrocyte energy metabolism and function phenotype. Our study provides a potential mechanism which may underlie the diabetic cerebral neuropathy and warrant further in vivo study to determine the effect of hyperglycemia on astrocyte metabolism and function.Item miRNA Profiling of Human Optic Nerve Head Astrocytes Exposed to Cyclic Stretch(2021-05) Rangan, Rajiv S.; Tovar-Vidales, Tara; Clark, Abbot F.; Liu, YangGlaucoma is a leading cause of irreversible blindness. Vision loss results from the degeneration and death of retinal ganglion cells (RGCs) and their axons. The primary risk factor for glaucoma is increased intraocular pressure (IOP) (2). Elevated IOP results in aberrations in the biomechanical properties of ocular tissues - including the transmission of biomechanical stretch through the reticulated, fibroelastic region of the optic nerve head (ONH) known as the lamina cribrosa (LC) (6). Cells of the LC are sensitive to biomechanical stretch and respond to increased stretch and pressure to promote the excessive synthesis of extracellular matrix (ECM) proteins and ECM remodeling (15,17). These responses promote a fibrotic environment within the LC that can cause mechanical damage to the axons of RGCs. ONH astrocytes represent one of the major cell types of the LC and are believed to contribute significantly to pathological ECM remodeling at the LC during glaucoma (11). ONH astrocytes also demonstrate a dysregulated pattern of protein expression when exposed to stretch (17). The mechanism that underlies this stretch-induced, aberrant dysregulation is unknown. MicroRNA (miRNA) dysregulation may represent one of the mechanisms contributing to the differential protein expression patterns seen in ONH astrocytes exposed to stretch. In this study we examine the miRNA profiles of ONH astrocytes exposed to cyclic stretch.Item Stretch stress propels glutamine dependency and glycolysis in optic nerve head astrocytes(Frontiers Media S.A., 2022-08-05) Pappenhagen, Nathaniel; Yin, Eric; Morgan, Autumn B.; Kiehlbauch, Charles C.; Inman, Denise M.Glaucoma is an optic neuropathy that leads to irreversible blindness, the most common subtype of which is typified by a chronic increase in intraocular pressure that promotes a stretch injury to the optic nerve head. In rodents, the predominant glial cell in this region is the optic nerve head astrocyte that provides axons with metabolic support, likely by releasing lactate produced through astrocytic glycolysis. Our primary hypothesis is that stretching of the optic nerve head astrocytes alters their metabolic activity, thereby advancing glaucoma-associated degeneration by compromising the metabolic support that the astrocytes provide to the axons in the optic nerve head. Metabolic changes in optic nerve head astrocytes were investigated by subjecting them to 24 h of 12% biaxial stretch at 1 Hz then measuring the cells' bioenergetics using a Seahorse XFe24 Analyzer. We observed significant glycolytic and respiratory activity differences between control and stretched cells, including greater extracellular acidification and lower ATP-linked respiration, yet higher maximal respiration and spare capacity in stretched optic nerve head astrocytes. We also determined that both control and stretched optic nerve head astrocytes displayed a dependency for glutamine over pyruvate or long-chain fatty acids for fuel. The increased use of glycolysis as indicated by the extracellular acidification rate, concomitant with a dependency on glutamine, suggests the need to replenish NAD + for continued glycolysis and provision of carbon for TCA cycle intermediates. Stretch alters optic nerve astrocyte bioenergetics to support an increased demand for internal and external energy.